MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,329 | +45.9% | 2,637 | +19.4% | 0.00% | +50.0% |
| Q2 2023 | $57,121 | +99.5% | 2,208 | +85.2% | 0.00% | +100.0% |
| Q1 2023 | $28,632 | +11.9% | 1,192 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,580 | +2.3% | 1,192 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | +8.7% | 1,192 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $23,000 | +360.0% | 1,192 | +429.8% | 0.00% | – |
| Q1 2022 | $5,000 | +25.0% | 225 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 225 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 225 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 225 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +200.0% | 225 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |